ArticleJAMA oncology2022

To Treat or Not to Treat Men With Low-risk or Intermediate-risk Prostate Cancer-Weighing the Evidence.

Susan Halabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.